Showing results (351-360 of 1,682) with videos related to
Sort By:
Pageof 169
The British Journal of Clinical Psychology|October 15, 2008
An effectiveness trial of cognitive behaviour therapy in a representative sample of outpatients with psychosisJohn Farhall, Nerelie C Freeman, Frances Shawyer, et al.BMJ (Clinical Research Ed.)|July 9, 2011
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient dataJohn C Pickup, Suzanne C Freeman, Alex J SuttonJournal of Addictive Diseases|January 1, 1995
Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New JerseyR C Freeman, G M Rodriguez, J F FrenchSTAR Protocols|October 26, 2023
Protocol for establishing a protein interactome based on close physical proximity to a target protein within live budding yeastJanhavi A Kolhe, Neethu L Babu, Brian C FreemanBiorxiv : the Preprint Server for Biology|October 10, 2024
Nuclear Type I Myosins are Essential for Life and Genome OrganizationAudrey Yi Tyan Peng, Jianhui Li, Brian C FreemanThe Journal of Pharmacy and Pharmacology|September 1, 1982
A study of the effects of nabumetone (BRL 14777), a novel anti-inflammatory drug, on cell infiltration into sterile cotton pellets implanted in ratsP C Freeman, F R Mangan, D K WatkinsGenes & Development|August 6, 2026
Nuclear type I myosins actively support nucleolar and nuclear structure and functionAudrey Yi Tyan Peng, Jianhui Li, Brian C FreemanPediatric Neurosurgery|March 9, 2000
Syndrome of overdrainage associated with disconnection of a ventriculoperitoneal shuntG Rosenthal, S Pomeranz, S Spektor, et al.Catheterization and Cardiovascular Diagnosis|October 1, 1993
Use of the stiff shaft, straight Terumo Glidewire in crossing stenotic aortic valvesS K Sharma, D H Israel, K Kumar, et al.European Journal of Neurology|June 2, 2007
The use of gabapentin in chronic cluster headache patients refractory to first-line therapyS Schuh-Hofer, H Israel, L Neeb, et al.Pageof 169